An abstract image of flowing color waves

UWARN addresses emerging viral infectious diseases by carrying out research with collaborating partner research laboratories in Brazil, Pakistan, Senegal, South Africa and Taiwan.

This is unpublished




UWARN Data management portal.

The University of Washington, and collaborators at Rockefeller University (NYC), FIOCRUZ (Brazil), IRESSEF (Senegal), KRISP (South Africa), Aga Khan University (Pakistan) and Chang Gung University (Taiwan) were awarded a NIH National Institutes of Allergy and Infectious Disease (NIAID) Centers for Research in Emerging Infectious Diseases (CREID) grant for $8.75 M for 5 years to form the United World for Antiviral Research Network (UWARN).


Questions? Contact us at UWARN@uw.edu 

UWARN research will develop innovative diagnostic reagents, including human viral-neutralizing antibodies and designed proteins that release light when antibodies to virus are present in blood (LOCKR technology from IPD). UWARN research will also improve understanding of how viruses manipulate the human immune system, facilitating development of better biomarkers to predict severe disease as well as host-directed therapies that could improve outcomes of viral infection.

UWARN will serve as one of ten NIAID Centers in the CREID Network, consisting of multidisciplinary teams of investigators, working in over 30 countries. The CREID network will be coordinated by the Research Triangle Institute (RTI), a large nonprofit research organization with regional and project offices in over 75 countries, and Duke University, a premier university known for its cutting-edge medical research and home to the Duke Human Vaccine Institute. Together they will serve as the CREID Coordination Center (CC).

A global effort

A map showing all of the UWARN lab locations across the world

The timing is critical, as UWARN will provide surveillance for emerging pandemic viruses, develop urgently needed diagnostics and therapeutics, and expand understanding of viral immune responses, which is key to vaccine development.

“We are very excited to establish UWARN, and the new collaborations with the five overseas partners to better address viral pandemics.” - Wes C. Van Voorhis, Co-Director of CERID

Wesley C. Van Voorhis Co-Director of the Center for Emerging and Reemerging Infectious Disease (CERID) brought together top investigators from the University of Washington, Fred Hutchinson Cancer Research Center, the Institute of Protein Design (IPD), the Rockefeller University and abroad to form the United World Antiviral Research Network (UWARN). Van Voorhis stated: “We are very excited to establish UWARN, and the new collaborations with the five overseas partners to better address viral pandemics.”

CREID logo

NIAID Awards Announcement

NIAID Establishes Centers for Research in Emerging Infectious Diseases

learn more

Our Partners


learn more
CREID logo

The CREID Pilot Research Program 2024 has been officially launched

Please click here for more information.

learn more